Zollinger‑Ellison Physical Fatigue: A Comprehensive Medical Guide

Overview

Zollinger‑Ellison syndrome (ZES) is a rare, hormone‑producing tumor (gastrinoma) that causes excessive gastric acid secretion. While the hallmark symptoms are severe peptic ulcers and diarrhea, many patients also experience physical fatigue that can be profound enough to interfere with daily life.

• What it is: Fatigue secondary to the metabolic, nutritional, and systemic effects of uncontrolled acid hypersecretion in ZES.
• Who it affects: Adults 30–60 years old are most commonly diagnosed, with a slight male predominance (≈ 55 %).
• Prevalence: ZES accounts for <0.1 % of all gastrointestinal (GI) tumors. Physical fatigue is reported in 47‑68 % of ZES patients, according to case series from the Mayo Clinic and Cleveland Clinic.^[1][2]

Symptoms

Physical fatigue in ZES often co‑exists with classic gastrointestinal manifestations. The full symptom picture may include:

General Fatigue

• Persistent tiredness: Feeling exhausted despite adequate rest.
• Reduced stamina: Difficulty completing routine tasks such as walking a short distance or climbing stairs.
• Morning lethargy: Waking up feeling unrefreshed.

Gastrointestinal Symptoms

• Recurrent or refractory peptic ulcers (often multiple and distal to the duodenum).
• Profuse, watery diarrhea (up to 6–8 stools/day).
• Abdominal pain or cramping.
• Heartburn and gastroesophageal reflux disease (GERD).

Metabolic & Nutritional Signs

• Weight loss despite normal or increased appetite.
• Vitamin B12, iron, and calcium deficiencies (due to malabsorption from chronic diarrhea).
• Electrolyte disturbances (hypokalemia, metabolic alkalosis).

Other Systemic Features

• Muscle weakness or cramps.
• Joint aches.
• Sleep disturbances (often secondary to nocturnal acid reflux).
• Psychological impact – irritability, difficulty concentrating (“brain fog”).

Causes and Risk Factors

Physical fatigue in ZES is not a primary disease but a consequence of several inter‑related mechanisms.

Underlying Pathophysiology

• Excess gastric acid: Leads to ulceration, chronic GI bleeding, and malabsorption of nutrients.
• Diarrhea: Causes fluid and electrolyte loss, which contributes to fatigue.
• Malnutrition: Deficiencies of iron, B12, folate, and vitamin D impair red‑blood‑cell production and muscle function.
• Inflammatory cytokines: Chronic acid injury stimulates systemic inflammation, a recognized driver of fatigue.

Risk Factors for Developing Zollinger‑Ellison Syndrome

• Genetic predisposition – Multiple Endocrine Neoplasia type 1 (MEN‑1) mutation (≈ 25‑30 % of ZES cases).
• Family history of gastrin‑producing tumors.
• Age 30‑60 years (peak incidence).
• Male sex (slightly higher prevalence).
• Chronic use of proton‑pump inhibitors (PPIs) may mask early symptoms, delaying diagnosis and allowing fatigue to worsen.

Diagnosis

Diagnosing fatigue related to ZES follows the standard work‑up for the underlying gastrinoma, then assessing the fatigue’s extent.

Initial Evaluation

• History & Physical Exam: Focus on ulcer history, stool frequency, weight changes, and fatigue severity (e.g., using the Fatigue Severity Scale).
• Laboratory Tests:
  • Serum fasting gastrin level (≥ 1000 pg/mL strongly suggests gastrinoma).
  • Complete blood count (CBC) for anemia.
  • Electrolytes, magnesium, calcium, and renal function.
  • Vitamin B12, folate, iron studies.

Imaging & Localization

• Somatostatin receptor scintigraphy (Octreoscan) or Ga‑68 DOTATATE PET/CT: Most sensitive for locating gastrinomas.
• CT or MRI abdomen: Detects primary tumor and liver metastases.
• Endoscopic ultrasound (EUS): Helpful for small (< 2 cm) pancreatic lesions.

Assessing Fatigue

• Standardized questionnaires (e.g., Fatigue Severity Scale, PROMIS Fatigue Short Form).
• Rule out other causes: thyroid function tests, sleep study (if sleep apnea suspected), depression screening.

Treatment Options

Treatment aims to control acid hypersecretion, eradicate or control the gastrinoma, correct nutritional deficiencies, and directly address fatigue.

Acid Suppression (First‑Line)

• High‑dose Proton‑Pump Inhibitors (PPIs): Omeprazole 60 mg daily or equivalent; dose titrated to symptom control.^[3]
• Histamine‑2 receptor antagonists (H2 blockers): Used adjunctively if PPIs alone are insufficient.

Surgical Management

• Enucleation or pancreaticoduodenectomy: Preferred for localized, non‑metastatic gastrinomas.
• Debulking surgery: For metastatic disease to reduce acid output.

Medical Oncology

• Somatostatin analogues (Octreotide, Lanreotide): Decrease gastrin secretion and can improve fatigue by reducing diarrhea.
• Targeted therapy (everolimus, sunitinib): Used in progressive metastatic disease.
• Chemotherapy: Reserved for aggressive, refractory tumors.

Addressing Nutritional Deficiencies

• Oral or intravenous iron and vitamin B12 supplementation.
• Calcium + vitamin D with bisphosphonate therapy if bone loss documented.
• High‑protein, low‑fat diet to reduce diarrhea frequency.

Fatigue‑Specific Interventions

• Structured exercise program (early‑stage aerobic activity 2–3 × /week).
• Cognitive‑behavioral therapy (CBT) for coping with chronic illness.
• Sleep hygiene education – consistent bedtime, avoid caffeine after 2 p.m., elevate head of bed.
• Psychiatric evaluation if depression or anxiety is present.

Living with Zollinger‑Ellison Physical Fatigue

Daily Management Tips

• Medication adherence: Take PPIs exactly as prescribed; missing doses can trigger acid rebound and worsen fatigue.
• Meal timing: Small, frequent meals (5–6 per day) reduce acid load and stabilize energy levels.
• Hydration: Replace fluids lost through diarrhea; oral rehydration solutions with electrolytes are helpful.
• Energy budgeting: Prioritize essential tasks, delegate when possible, and schedule rest breaks.
• Monitor weight & labs: Track weight weekly; repeat CBC, iron, B12, and electrolytes every 3‑6 months.
• Physical activity: Gentle walking or yoga improves circulation and reduces fatigue, but avoid overexertion.
• Stress reduction: Mindfulness, deep‑breathing, or short meditation sessions (5–10 min) can lower cortisol, which may worsen fatigue.

Support Resources

• National Neuroendocrine Tumor Society (NANETS) patient forums.
• Local dietitian experienced with malabsorption syndromes.
• Psychotherapy or support groups for chronic illness.

Prevention

Because ZES itself is largely non‑preventable, focus is placed on early detection and minimizing fatigue‑inducing complications.

• Screen high‑risk individuals: Annual fasting gastrin measurement for patients with MEN‑1 or known pancreatic neuroendocrine tumors.
• Avoid long‑term unsupervised PPI use: May mask early ulcer symptoms, delaying diagnosis.
• Prompt treatment of ulcers & diarrhea: Reduces chronic blood loss and nutrient loss.
• Vaccinations: Hepatitis B and pneumococcal vaccines for patients undergoing immunosuppressive therapy.

Complications

If physical fatigue caused by uncontrolled ZES is left untreated, the following complications may develop:

• Severe anemia: From chronic GI bleeding, leading to cardiac strain.
• Electrolyte imbalance: Persistent hypokalemia can cause arrhythmias.
• Osteoporosis/osteomalacia: Due to chronic acid loss of calcium and vitamin D.
• Malnutrition and cachexia: Worsening fatigue and reduced immune function.
• Metastatic disease progression: Uncontrolled gastrin secretion fuels tumor growth.
• Psychiatric morbidity: Depression, anxiety, and reduced quality of life.

When to Seek Emergency Care

---

References

1. Mayo Clinic Proceedings. “Zollinger‑Ellison Syndrome: Clinical Presentation and Management.” 2022.
2. Cleveland Clinic. “Neuroendocrine Tumors of the Pancreas.” 2023.
3. American College of Gastroenterology. “Guidelines for the Management of Gastric Acid Hypersecretion.” 2021.
4. NIH National Cancer Institute. “Neuroendocrine Tumors Treatment (PDQ®)–Health Professional Version.” Updated 2024.
5. World Health Organization. “Classification of Tumours of the Digestive System.” 5th ed., 2024.